Sep 25, 2026 · 29 min
A two-hour brain-tumour test could reshape surgery
Rapid new test transforms brain tumour diagnosis
The episode connects a potentially transformative medical advance with conflicts, disasters and policy debates where speed and preparedness have immediate consequences.
- 1A genomic test can identify glioblastoma during surgery, allowing doctors to begin treatment planning weeks earlier.
- 2Ukraine’s proposed Patriot production offers strategic independence but cannot quickly solve shortages of costly missile interceptors.
- 3Reports from Congo, Nepal and the beauty industry show how weak systems leave people exposed to preventable risks.
Don't miss
Steve Palmer’s operation illustrates the moment a genomic test can identify a brain tumour while surgery is still underway.
The brief
A genomic test trialled at Nottingham University Hospital can identify brain tumours during surgery in about two hours, replacing weeks of uncertainty with an earlier treatment plan.
Steve Palmer’s operation shows the human stakes of a faster diagnosis, while neurosurgeon Stuart Smith explains how identifying glioblastoma sooner can change what follows.
Ukraine says it may receive a licence to produce Patriot interceptors, but the proposal offers no immediate fix: building capacity could take up to two years, and the weapons remain scarce and expensive.
The episode then follows Mary Jane Veloso’s return after nearly 15 years on death row, Ebola pressures in Congo, and Nepal’s underfunded recovery from deadly floods.
Children’s beauty routines raise questions about social-media influence and ingredient safety, while Pope Leo XIV argues that AI and assisted dying must be judged against human dignity.
Jonathan HeadMentioned
Volodymyr Zelenskyy
Pope Leo XIVListen to the full episode and explore every guest, topic, and moment on PodLume.